Podcast: Opportunities for biotechs in precision medicine, driving value and bringing important new therapies to patients

March 4, 2020 PAREXEL

Within the past 20 years, the field of precision medicine has been transformed. For biotech companies, this new landscape holds tremendous promise for innovation. So, why aren’t more companies leveraging this approach? In this episode, Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss this conundrum, and what biotechs should be thinking about right from the start, to open up the opportunity for this approach to help bring innovation and new therapies to more patients.  

Previous Flipbook
Cell and gene therapies: for biotechs, collaboration is key to successful innovation
Cell and gene therapies: for biotechs, collaboration is key to successful innovation

Learn more about what to look for in the right CRO partner to overcome logistical and operational challenge...

Next Video
Endpoints That Matter
Endpoints That Matter

Parexel’s Andreas Reiff, VP, Global TA Head, Inflammation/Immunology talks with Julie Stover, Senior Direct...